Habitual physical activity is associated with circulating irisin in healthy controls but not in subjects with diabetes mellitus type 2

European Journal of Clinical Investigation

Volumn 45, Issue 8, 2015, Pages 775-781

  Al Daghri, Nasser M ^a   Alokail, Majed S ^a   Rahman, Shakilur ^a   Amer, Osama E ^a   Al Attas, Omar S ^a   Alfawaz, Hanan ^a,b   Tripathi, Gyanendra ^c   Sabico, Shaun ^a   Chrousos, George P ^d   Mcternan, Philip G ^c   Piya, Milan K ^c  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Diabetes; Frequency intensity time index; Irisin; Physical activity

Indexed keywords

GLUCOSE; IRISIN; LIPID; FIBRONECTIN; FNDC5 PROTEIN, HUMAN;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENERGY EXPENDITURE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE; EXERCISE INTENSITY; FEMALE; GLUCOSE BLOOD LEVEL; HABIT; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PRIMARY HEALTH CARE; PRIORITY JOURNAL; QUESTIONNAIRE; SAUDI; TIME; WHITE ADIPOCYTE; BLOOD; CASE CONTROL STUDY; MIDDLE AGED; MOTOR ACTIVITY; SAUDI ARABIA;

ADULT; AGED; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRONECTINS; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; SAUDI ARABIA;

EID: 84937739581     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12468     Document Type: Article

References (42)

1. Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012;481:463-8.
2. Lecker SH, Zavin A, Cao P, Arena R, Allsup K, Daniels KM et al. Expression of the irisin precursor FNDC5 in skeletal muscle correlates with aerobic exercise performance in patients with heart failure. Circ Heart Fail 2012;5:812-8.
3. Wu J, Bostrom P, Sparks LM, Ye L, Choi JH, Giang A-H et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 2012;150:366-76.
4. Swick AG, Orena S, O'Connor A. Irisin levels correlate with energy expenditure in a subgroup of humans with energy expenditure greater than predicted by fat free mass. Metabolism 2013;62:1070-3.
5. Kokkinos P, Myers J. Exercise and physical activity clinical outcomes and applications. Circulation 2010;122:1637-48.
6. Haskell WL, Lee I, Pate RR, Powell KE, Blair SN, Franklin BA et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 2007;39:1423.
7. Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR et al. Exercise and Type 2 Diabetes The American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care 2010;33:e147-67.
8. Egan B, Zierath JR. Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metab 2013;17:162-84.
9. Wen CP, Wai JPM, Tsai MK, Yang YC, Cheng TYD, Lee M-C et al. Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study. The Lancet 2011;378:1244-53.
10. Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 2012;61:1725-38.
11. Kraemer RR, Shockett P, Webb ND, Shah U, Castracane VD. A transient elevated irisin blood concentration in response to prolonged, moderate aerobic exercise in young men and women. Horm Metab Res 2014;46:150-4.
12. Huh JY, Mougios V, Skraparlis A, Kabasakalis A, Mantzoros CS. Irisin in response to acute and chronic whole-body vibration exercise in humans. Metabolism 2014;63:918-21.
13. Polyzos SA, Kountouras J, Shields K, Mantzoros CS. Irisin: a renaissance in metabolism. Metabolism 2013;62:1037-44.
14. Bluher S, Panagiotou G, Petroff D, Markert J, Wagner A, Klemm T et al. Effects of a 1-year exercise and lifestyle intervention on irisin, adipokines, and inflammatory markers in obese children. Obesity 2014;22:1701-8.
15. Pekkala S, Wiklund PK, Hulmi JJ, Ahtiainen JP, Horttanainen M, Pollanen E et al. Are skeletal muscle FNDC5 gene expression and irisin release regulated by exercise and related to health? J Physiol 2013;591:5393-400.
16. Hecksteden A, Wegmann M, Steffen A, Kraushaar J, Morsch A, Ruppenthal S et al. Irisin and exercise training in humans-Results from a randomized controlled training trial. BMC Med 2013;11:235.
17. Norheim F, Langleite TM, Hjorth M, Holen T, Kielland A, Stadheim HK et al. The effects of acute and chronic exercise on PGC-1α, irisin and browning of subcutaneous adipose tissue in humans. FEBS J 2014;281:739-49.
18. Kurdiova T, Balaz M, Vician M, Maderova D, Vlcek M, Valkovic L et al. Are skeletal muscle & adipose tissue Fndc5 gene expression and irisin release affected by obesity, diabetes and exercise? In vivo & in vitro studies. J Physiol 2014;592:1091-107.
19. Timmons JA, Baar K, Davidsen PK, Atherton PJ. Is irisin a human exercise gene? Nature 2012;488:E9-10.
20. Choi Y-K, Kim M-K, Bae KH, Seo H, Jeong J-Y, Lee W-K et al. Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract 2013;100:96-101.
21. Liu J-J, Wong MD, Toy WC, Tan CS, Liu S, Ng XW et al. Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complications 2013;27:365-9.
22. Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab 2013;98:E769-78.
23. Park KH, Zaichenko L, Brinkoetter M, Thakkar B, Sahin-Efe A, Joung KE et al. Circulating Irisin in relation to insulin resistance and the metabolic syndrome. J Clin Endocrinol Metab 2013;98:4899-907.
24. Stengel A, Hofmann T, Goebel-Stengel M, Elbelt U, Kobelt P, Klapp BF. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity-Correlation with body mass index. Peptides 2013;39:125-30.
25. Piya MK, Harte AL, Sivakumar K, Tripathi G, Voyias PD, James S et al. The identification of irisin in human cerebrospinal fluid: influence of adiposity, metabolic markers and gestational diabetes. Am J Physiol Endocrinol Metab 2014;306:E512-8.
26. Boström PA, Fernández-Real JM, Mantzoros C. Irisin in humans: recent advances and questions for future research. Metab: Clin Exp 2014;63:178.
27. Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Yousef M, Sabico SL et al. Diabetes mellitus type 2 and other chronic non-communicable diseases in the central region, Saudi Arabia (Riyadh cohort 2): a decade of an epidemic. BMC Med 2011;9:76.
28. Al-Nozha MM, Al-Hazzaa HM, Arafah MR, Al-Khadra A, AlMazrou YY, Al-Maatouq MA et al. Prevalence of physical activity and inactivity among Saudis aged 30-70 years: a population-based cross-sectional study. Saudi Med J 2007;28:559-68.
29. Al-Daghri NM, Alkharfy KM, Al-Saleh Y, Al-Attas OS, Alokail MS, Al-Othman A et al. Modest reversal of metabolic syndrome manifestations with vitamin D status correction: a 12-month prospective study. Metabolism 2012;61:661-6.
30. Kasari DS. The effects of exercise on serum lipid levels in college women. Unpublished master's thesis. University of Montana; 1976.
31. Lease HJ, Bond MJ. Correspondence between alternate measures of maladaptive exercise, and their associations with disordered eating symptomatology. J Behav Addict 2013;2:153-9.
32. McKune AJ, Semple SJ, Smith LL, Wadee AA. Complement, immunoglobulin and creatine kinase response in black and white males after muscle-damaging exercise. S Afr J Sports Med 2009;21:47-52.
33. Sharkey BJ, Gaskill SE. Fitness and Health, 6th edn: Champaign, IL: Human Kinetics; 2007.
34. Hume R. Prediction of lean body mass from height and weight. J Clin Pathol 1966;19:389-91.
35. Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Yousef M, Vinodson B et al. Maternal inheritance of circulating irisin in humans. Clin Sci 2014;126:837-44.
36. Al-Daghri NM, Alkharfy KM, Rahman S, Amer OE, Vinodson B, Sabico S et al. Irisin as a predictor of glucose metabolism in children: sexually dimorphic effects. Eur J Clin Invest 2014;44:119-24.
37. Bostrom PA, Fernández-Real JM. Metabolism: irisin, the metabolic syndrome and follistatin in humans. Nat Rev Endocrinol 2014;10:11-2.
38. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci 2003;100:8466-71.
39. Skov V, Glintborg D, Knudsen S, Jensen T, Kruse TA, Tan Q et al. Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome. Diabetes 2007;56:2349-55.
40. Højlund K, Boström P. Irisin in obesity and type 2 diabetes. J Diabetes Complications 2013;27:303-4.
41. Hernández-Alvarez MI, Thabit H, Burns N, Shah S, Brema I, Hatunic M et al. Subjects with early-onset type 2 diabetes show defective activation of the skeletal muscle PGC-1α/mitofusin-2 regulatory pathway in response to physical activity. Diabetes Care 2010;33:645-51.
42. Huh JY, Mougios V, Kabasakalis A, Fatouros I, Siopi A, Douroudos II et al. Exercise-induced irisin secretion is independent of age or fitness level and increased irisin may directly modulate muscle metabolism through AMPK activation. J Clin Endocrinol Metab 2014;99:2154-61.